Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vitamin D vs. calcium

This article was originally published in The Tan Sheet

Executive Summary

Daily calcium intake of over 800 mg may not be as important as maintaining adequate vitamin D status, according to a study published in the Journal of the American Medical Association Nov. 9. The cross-sectional study of 2,310 healthy Icelandic adults age 30-85. Laufey Steingrimsdottir, Public Health Institute of Iceland, et al., observed the effect the nutrients on calcium homeostatis, "as determined by serum intact parathyroid hormone (PTH)." Subjects completed food frequency questionnaires and were divided according to calcium levels. "Vitamin D sufficiency can ensure ideal serum PHT values even when the calcium intake level is less than 800 mg/day," authors conclude. Alternatively, high calcium intake (more than 1200 mg/day) and low vitamin D did not contribute to ideal levels...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098837

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel